Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review

To assess the effects of pembrolizumab monotherapy versus chemotherapy for the second-line treatment of advanced urothelial carcinoma.

This is a protocol.

Share/Save
Health topics: